• J Arthroplasty · May 2016

    Randomized Controlled Trial Multicenter Study Comparative Study

    Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.

    • Wayne T North, Nima Mehran, Jason J Davis, Craig D Silverton, Robb M Weir, and Michael W Laker.
    • Division of adult reconstructive surgery, Henry Ford Hospital, Detroit, Michigan.
    • J Arthroplasty. 2016 May 1; 31 (5): 1022-6.

    BackgroundTranexamic acid (TXA) reduces perioperative blood loss in total hip arthroplasty (THA).MethodsIn our randomized control trial, 139 patients were enrolled and received 2 g of either topical or intravenous (IV) TXA. Preoperative and postoperative protocols were standardized.ResultsCalculated blood and Hgb loss were lower in the IV group (1195.0 ± 485.9 mL, 1442.7 ± 562.7 mL; P = .006), (160.3 [g] ± 63.8, 188.4 [g] ± 68.5; P = .014). There was a trend toward significance in transfusion reduction (11% [IV] vs 18% [topical]; P = .3). Both groups effectively reduced the transfusion rate. There was significant financial incentive for the use of TXA in THA with a savings of $314 per patient.ConclusionsIV and topical TXA are effective tools to reduce blood loss and transfusion costs in THA, and we recommend the IV form for ease of use.Copyright © 2016 Elsevier Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.